Mladen Marinkovic, Radiation Oncologist at Institute for Oncology and Radiology of Serbia, shared a post on LinkedIn:
“Just got back from European Society for Radiotherapy and Oncology (ESTRO) Annual Congress in Vienna — an amazing week full of learning, sharing, and connecting!
I had the chance to present two digital posters on rectal cancer, focusing on prognostic factors and predictive biomarkers for response to neoadjuvant chemoradiotherapy, as part of the STEPUPIORS Twinning Project.
It was inspiring to dive into the latest in radiation oncology, personalized treatment, and the role of AI in clinical practice — and to connect with colleagues from across Europe.”
More posts featuring ESTRO on OncoDaily.
